Skip to content
OpenCapital
Get started

Abeona Therapeutics Inc. ABEO Q1 2026 earnings

Reported May 13, 2026 · Before market open

Revenue$8.7MBeat by $4.1MDiluted EPS-$0.30Beat by $0.03
Revenue estimate$4.6M
EPS estimate-$0.33

Next report

Aug 13, 2026 (in a month)
Revenue estimate$12.2M
EPS estimate-$0.23

Versus estimates

Revenue

Q1 2026$8.7MBeat by $4.1M
Q4 2025$5.4MBeat by $975.5KQ2 2025$400.0KMiss by $6.1M

Diluted EPS

Q1 2026-$0.30Beat by $0.03
Q4 2025-$0.34Beat by $0.01Q3 2025-$0.10Beat by $0.17Q2 2025$1.71Beat by $2.10Q1 2025-$0.24Beat by $0.11Q4 2024-$0.24Beat by $0.19

Ask the moment Abeona Therapeutics Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Abeona Therapeutics Inc. report Q1 2026 earnings?
Abeona Therapeutics Inc. (ABEO) reported Q1 2026 earnings on May 13, 2026 before market open.
What were Abeona Therapeutics Inc.'s Q1 2026 revenue and EPS?
Abeona Therapeutics Inc. reported revenue of $8.7M and diluted EPS of $-0.30 for Q1 2026.
Did Abeona Therapeutics Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $4.6M by $4.1M. EPS beat the consensus estimate of $-0.33 by $0.03.
How did Abeona Therapeutics Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 25.0% from $-0.24.
Where can I find Abeona Therapeutics Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-022610) and the 10-Q periodic report (0001493152-26-022614) directly on SEC EDGAR. The filing index links above go to sec.gov.